New publications
Scientists intend to create a human simulator for drug testing
Last reviewed: 01.07.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Scientists intend to create a human body simulator for drug testing. The new technology will allow drug manufacturers to quickly test new drugs and move on to clinical trials faster and more safely.
Experts from the Massachusetts Institute of Technology have received an order from the scientific defense agency DARPA and the US National Institutes of Health to develop a simulator of the human body, which will increase the efficiency and speed of pharmaceutical testing.
The BIO-MIMETICS project will create an electromechanical simulator of the human body that will allow observing various reactions to drugs. This platform will simulate human physiology in laboratory conditions, using an array of microfluidic chips, electronic control systems, human living cells and tissues.
The model will simulate the functioning of the circulatory system, the immune and endocrine systems, the gastrointestinal tract, the skin, as well as the musculoskeletal, nervous, reproductive, respiratory and urinary systems.
The goal of this program is to create a universal platform capable of accurately predicting the consequences of using a particular drug or toxic substance. Thanks to the new technology, drug manufacturers will be able to quickly test new drugs and move on to clinical trials faster and safer. Thus, promising drugs that save from many dangerous diseases will appear on pharmacy shelves much earlier.
Let us recall that last month, the first robot that distributes medications to patients began working in one of the Israeli hospitals. Its advantages are obvious: it does not allow errors in dosages, saves time for medical personnel. The hospital doctors consider these changes revolutionary. The intense work of medical personnel in the departments sometimes causes errors in distributing medications. This can happen due to the difficulty in understanding the doctor's handwriting, the wrong drug or its dosage. The robotic system is accurate. Its focus is not only on dosage and sensitivity to drugs, but also on preventing possible unwanted interactions between individual drugs.
The system pays special attention to the accounting and distribution of narcotic drugs.
[